End-of-day quote
Shenzhen S.E.
23:00:00 23/06/2024 BST
|
5-day change
|
1st Jan Change
|
10.04
CNY
|
-5.37%
|
|
-7.64%
|
-37.05%
|
Fiscal Period: December |
2023
|
---|
Capitalization
1 |
6,380
|
Enterprise Value (EV)
1 |
6,413
|
P/E ratio
|
55
x
|
Yield
|
0.63%
|
Capitalization / Revenue
|
1.68
x
|
EV / Revenue
|
1.69
x
|
EV / EBITDA
|
37.6
x
|
EV / FCF
|
29,260,372
x
|
FCF Yield
|
0%
|
Price to Book
|
3.28
x
|
Nbr of stocks (in thousands)
|
400,010
|
Reference price
2 |
15.95
|
Announcement Date
|
28/04/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
1,105
|
1,522
|
1,931
|
2,339
|
3,262
|
3,797
|
EBITDA
1 |
49.3
|
89.02
|
130.8
|
117.3
|
234.3
|
170.6
|
EBIT
1 |
43.89
|
82
|
121.8
|
106.5
|
222.5
|
150.4
|
Operating Margin
|
3.97%
|
5.39%
|
6.31%
|
4.56%
|
6.82%
|
3.96%
|
Earnings before Tax (EBT)
1 |
37.62
|
77.21
|
123
|
94.22
|
214.7
|
151.5
|
Net income
1 |
19.5
|
51.95
|
88.92
|
69.73
|
160.8
|
114.7
|
Net margin
|
1.77%
|
3.41%
|
4.61%
|
2.98%
|
4.93%
|
3.02%
|
EPS
2 |
0.0700
|
0.1600
|
0.2600
|
0.2100
|
0.4700
|
0.2900
|
Free Cash Flow
|
-
|
-56.42
|
2.702
|
227.8
|
128.8
|
219.2
|
FCF margin
|
-
|
-3.71%
|
0.14%
|
9.74%
|
3.95%
|
5.77%
|
FCF Conversion (EBITDA)
|
-
|
-
|
2.07%
|
194.22%
|
54.98%
|
128.5%
|
FCF Conversion (Net income)
|
-
|
-
|
3.04%
|
326.73%
|
80.12%
|
191.14%
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
0.1000
|
Announcement Date
|
07/05/21
|
07/05/21
|
07/05/21
|
09/02/23
|
10/04/23
|
28/04/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
-
|
-
|
-
|
313
|
280
|
32.9
|
Net Cash position
1 |
64.2
|
20.1
|
120
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
2.667
x
|
1.195
x
|
0.1927
x
|
Free Cash Flow
|
-
|
-56.4
|
2.7
|
228
|
129
|
219
|
ROE (net income / shareholders' equity)
|
-
|
10.6%
|
14.1%
|
9.3%
|
18.5%
|
8.05%
|
ROA (Net income/ Total Assets)
|
-
|
5.04%
|
6.47%
|
4.09%
|
6.12%
|
2.62%
|
Assets
1 |
-
|
1,030
|
1,374
|
1,705
|
2,628
|
4,383
|
Book Value Per Share
2 |
1.640
|
1.650
|
2.100
|
2.310
|
2.790
|
4.860
|
Cash Flow per Share
2 |
0.5900
|
0.4100
|
0.6100
|
0.8400
|
1.420
|
3.340
|
Capex
1 |
22.6
|
44.1
|
55.3
|
33.9
|
105
|
216
|
Capex / Sales
|
2.05%
|
2.9%
|
2.87%
|
1.45%
|
3.21%
|
5.7%
|
Announcement Date
|
07/05/21
|
07/05/21
|
07/05/21
|
09/02/23
|
10/04/23
|
28/04/24
|
|
1st Jan change
|
Capi.
|
---|
| -37.05% | 553M | | -39.87% | 13.73B | | -42.20% | 9.46B | | -21.70% | 7.11B | | -6.45% | 5.88B | | +78.71% | 4.79B | | -4.09% | 4.54B | | +3.97% | 4.44B | | -21.06% | 4.35B | | -18.27% | 2.64B |
Other Drug Retailers
|